BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16617183)

  • 1. Treatment for gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
    Maeda T; Niitsu N
    Intern Med; 2006; 45(6):353-4. PubMed ID: 16617183
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter-independent, chemotherapy-resistant, radiosensitive gastric MALT lymphoma with massive deposits of amyloidlike substance.
    Matsumoto H; Koga H; Iida M; Suekane H; Tarumi K; Hoshika K; Mikami Y; Haruma K
    Dig Dis Sci; 2003 Oct; 48(10):2018-22. PubMed ID: 14627350
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
    Sugimoto M; Kajimura M; Shirai N; Furuta T; Kanaoka S; Ikuma M; Sato Y; Hishida A
    Intern Med; 2006; 45(6):405-9. PubMed ID: 16617193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori eradication therapy in primary high-grade gastric MALT lymphoma.
    Fischbach W
    Gastroenterology; 2002 Jul; 123(1):393. PubMed ID: 12105882
    [No Abstract]   [Full Text] [Related]  

  • 5. Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages.
    Cheung DY
    Gut Liver; 2016 Sep; 10(5):659-60. PubMed ID: 27563015
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment Strategy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Nakamura S; Matsumoto T
    Gastroenterol Clin North Am; 2015 Sep; 44(3):649-60. PubMed ID: 26314674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
    Ferreri AJ; Govi S; Ponzoni M
    Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori associated gastric B cell MALT lymphoma: predictive factors for regression.
    Morgner A; Bayerdörffer E; Neubauer A; Stolte M
    Gut; 2001 Mar; 48(3):290-2. PubMed ID: 11171813
    [No Abstract]   [Full Text] [Related]  

  • 9. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
    Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
    Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of gastric marginal zone lymphoma of MALT type.
    Stathis A; Bertoni F; Zucca E
    Expert Opin Pharmacother; 2010 Sep; 11(13):2141-52. PubMed ID: 20586708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric marginal zone lymphoma of mucosa-associated lymphoid tissue type: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Zucca E
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii59-60. PubMed ID: 17491050
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies.
    Isaacson PG; Diss TC; Wotherspoon AC; Barbazza R; De Boni M; Doglioni C
    Gastroenterology; 1999 Sep; 117(3):750-1. PubMed ID: 10490369
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
    Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
    Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastric MALT lymphoma, clinical features].
    Udvardy M
    Orv Hetil; 1999 Feb; 140(6):291-4. PubMed ID: 10071508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second complete remission of Helicobacter pylori negative gastric MALT lymphoma following antibiotic treatment.
    Troch M; Püspök A; Streubel B; Chott A; Raderer M
    Leuk Lymphoma; 2007 Jan; 48(1):204-6. PubMed ID: 17325871
    [No Abstract]   [Full Text] [Related]  

  • 17. [The gastric MALT lymphoma. An unforeseen model for studying the pathogenesis of the lymphomas].
    Savio A
    Recenti Prog Med; 2009 Jun; 100(6):311-21. PubMed ID: 19708303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of vitaflor to eradicate Helicobacter pylori in treatment of MALT-lymphoma of the stomach].
    Gershanovich ML; Petrov LN; Dobritsa VP; Kalinovskiĭ VP; Nikitina MV
    Vopr Onkol; 2006; 52(6):696-8. PubMed ID: 17338252
    [No Abstract]   [Full Text] [Related]  

  • 19. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori strikes again: gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
    Swisher SC; Barbati AJ
    Gastroenterol Nurs; 2007; 30(5):348-54; quiz 355-6. PubMed ID: 18049205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.